Matches in SemOpenAlex for { <https://semopenalex.org/work/W2679828402> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2679828402 abstract "9005Background: Adding bevacizumab to weekly paclitaxel (wPB) has shown synergistic effect and increased activity in various tumor types. The ULTIMATE study evaluated wPB vs. docetaxel (DOC) as 2nd or 3rd-line treatment in patients with advanced non-squamous NSCLC. Methods: Patients with non-squamous NSCLC progressing after 1 or 2 lines of treatment including platinum-based chemotherapy were randomized 2:1 (stratified by PS, previous lines, prior exposure to bevacizumab) to wPB (paclitaxel 90 mg/m² D1, 8, 15 and bevacizumab 10 mg/kg D1, 15, q28d) or DOC (75 mg/m² q21d) until progression. Patients were allowed to cross-over to the other arm following progression. The primary endpoint was progression-free survival (PFS). Results: From 05/2013 to 08/2014, 166 patients were randomized (wPB: 111, DOC: 55). Clinical characteristics were balanced between both arms. 31% had received previous bevacizumab and 69% had received 1 previous line of treatment. Median follow-up was 28.9 months. The adjusted hazard ratio ..." @default.
- W2679828402 created "2017-06-30" @default.
- W2679828402 creator A5002994604 @default.
- W2679828402 creator A5005673716 @default.
- W2679828402 creator A5009585365 @default.
- W2679828402 creator A5009687581 @default.
- W2679828402 creator A5023794502 @default.
- W2679828402 creator A5029973306 @default.
- W2679828402 creator A5030455508 @default.
- W2679828402 creator A5032393857 @default.
- W2679828402 creator A5039964156 @default.
- W2679828402 creator A5040192181 @default.
- W2679828402 creator A5061590911 @default.
- W2679828402 creator A5063103135 @default.
- W2679828402 creator A5065886715 @default.
- W2679828402 creator A5071118692 @default.
- W2679828402 creator A5077305357 @default.
- W2679828402 creator A5077576453 @default.
- W2679828402 creator A5080017656 @default.
- W2679828402 creator A5087836238 @default.
- W2679828402 date "2016-05-20" @default.
- W2679828402 modified "2023-10-03" @default.
- W2679828402 title "Weekly paclitaxel plus bevacizumab versus docetaxel as second or third-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC): Results from the phase III study IFCT-1103 ULTIMATE." @default.
- W2679828402 doi "https://doi.org/10.1200/jco.2016.34.15_suppl.9005" @default.
- W2679828402 hasPublicationYear "2016" @default.
- W2679828402 type Work @default.
- W2679828402 sameAs 2679828402 @default.
- W2679828402 citedByCount "15" @default.
- W2679828402 countsByYear W26798284022016 @default.
- W2679828402 countsByYear W26798284022017 @default.
- W2679828402 countsByYear W26798284022018 @default.
- W2679828402 countsByYear W26798284022019 @default.
- W2679828402 crossrefType "journal-article" @default.
- W2679828402 hasAuthorship W2679828402A5002994604 @default.
- W2679828402 hasAuthorship W2679828402A5005673716 @default.
- W2679828402 hasAuthorship W2679828402A5009585365 @default.
- W2679828402 hasAuthorship W2679828402A5009687581 @default.
- W2679828402 hasAuthorship W2679828402A5023794502 @default.
- W2679828402 hasAuthorship W2679828402A5029973306 @default.
- W2679828402 hasAuthorship W2679828402A5030455508 @default.
- W2679828402 hasAuthorship W2679828402A5032393857 @default.
- W2679828402 hasAuthorship W2679828402A5039964156 @default.
- W2679828402 hasAuthorship W2679828402A5040192181 @default.
- W2679828402 hasAuthorship W2679828402A5061590911 @default.
- W2679828402 hasAuthorship W2679828402A5063103135 @default.
- W2679828402 hasAuthorship W2679828402A5065886715 @default.
- W2679828402 hasAuthorship W2679828402A5071118692 @default.
- W2679828402 hasAuthorship W2679828402A5077305357 @default.
- W2679828402 hasAuthorship W2679828402A5077576453 @default.
- W2679828402 hasAuthorship W2679828402A5080017656 @default.
- W2679828402 hasAuthorship W2679828402A5087836238 @default.
- W2679828402 hasConcept C121608353 @default.
- W2679828402 hasConcept C126322002 @default.
- W2679828402 hasConcept C143998085 @default.
- W2679828402 hasConcept C168563851 @default.
- W2679828402 hasConcept C203092338 @default.
- W2679828402 hasConcept C207103383 @default.
- W2679828402 hasConcept C2776256026 @default.
- W2679828402 hasConcept C2776694085 @default.
- W2679828402 hasConcept C2777292972 @default.
- W2679828402 hasConcept C2777802072 @default.
- W2679828402 hasConcept C2780739268 @default.
- W2679828402 hasConcept C2781190966 @default.
- W2679828402 hasConcept C44249647 @default.
- W2679828402 hasConcept C71924100 @default.
- W2679828402 hasConceptScore W2679828402C121608353 @default.
- W2679828402 hasConceptScore W2679828402C126322002 @default.
- W2679828402 hasConceptScore W2679828402C143998085 @default.
- W2679828402 hasConceptScore W2679828402C168563851 @default.
- W2679828402 hasConceptScore W2679828402C203092338 @default.
- W2679828402 hasConceptScore W2679828402C207103383 @default.
- W2679828402 hasConceptScore W2679828402C2776256026 @default.
- W2679828402 hasConceptScore W2679828402C2776694085 @default.
- W2679828402 hasConceptScore W2679828402C2777292972 @default.
- W2679828402 hasConceptScore W2679828402C2777802072 @default.
- W2679828402 hasConceptScore W2679828402C2780739268 @default.
- W2679828402 hasConceptScore W2679828402C2781190966 @default.
- W2679828402 hasConceptScore W2679828402C44249647 @default.
- W2679828402 hasConceptScore W2679828402C71924100 @default.
- W2679828402 hasLocation W26798284021 @default.
- W2679828402 hasOpenAccess W2679828402 @default.
- W2679828402 hasPrimaryLocation W26798284021 @default.
- W2679828402 hasRelatedWork W2076178766 @default.
- W2679828402 hasRelatedWork W2104347254 @default.
- W2679828402 hasRelatedWork W2130652363 @default.
- W2679828402 hasRelatedWork W2134667653 @default.
- W2679828402 hasRelatedWork W2134693386 @default.
- W2679828402 hasRelatedWork W2140980839 @default.
- W2679828402 hasRelatedWork W2145835533 @default.
- W2679828402 hasRelatedWork W2156353875 @default.
- W2679828402 hasRelatedWork W2163351155 @default.
- W2679828402 hasRelatedWork W2170030318 @default.
- W2679828402 hasRelatedWork W2198093519 @default.
- W2679828402 hasRelatedWork W2293531514 @default.
- W2679828402 hasRelatedWork W2567564314 @default.
- W2679828402 isParatext "false" @default.
- W2679828402 isRetracted "false" @default.
- W2679828402 magId "2679828402" @default.
- W2679828402 workType "article" @default.